Clinical Research Directory

To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM

Sponsor: Korea University Anam Hospital

Summary

The goal of this Randomized controlled trials is to assess in the long term efficacy and safety of ezefeno. The primary endpoint are: * major adverse cardiovascular events within 48 months of the trial duration * microvascular events within 48 months of the trial duration

Official title: To Assess the Long-term Efficacy and Safety of Combined Therapy With Ezefeno Tab. in Patients With Dyslipidemia Who do Not Achieve Adequate Control of Non-HDL-C Levels Even With Moderate-intensity Monotherapy

Key Details

Conditions

Interventions

Locations (1)